Literature DB >> 25364945

Short- and long-term recidivism prediction of the PCL-R and the effects of age: a 24-year follow-up.

Mark E Olver1, Stephen C P Wong2.   

Abstract

We prospectively examined the short- and long-term prediction of several recidivism outcomes as a function of psychopathy and age in a sample of 273 Canadian federal inmates with an average 24 years post-release follow-up. Offenders were rated using the original 22-item Hare Psychopathy Checklist (PCL: Hare, 1980) based on extensive archival file information, and the ratings were used to compute the Psychopathy Checklist-Revised (Hare, 2003) and the 4 facet scores. PCL-R total scores and the Lifestyle and Antisocial facets, but not the Interpersonal and Affective facets, showed mostly small and some moderate predictive efficacy for general and nonviolent recidivism over 3-, 5-, 10-, and 20-year fixed follow-ups, and predicted violence recidivism at shorter follow-ups. Age at release was negatively correlated with all recidivism outcomes and follow-up periods for both high and low PCL-R rated offenders, and uniquely predicted all recidivism outcomes after controlling for the PCL-R using Cox regression survival analysis. Increased age was consistently linked to recidivism reduction even for psychopathic offenders. The results showed that both PCL-R scores and age contributed to the prediction of recidivism; however, the PCL-R facets made differential contributions that varied with the type of offense (violent vs. nonviolent) and follow-up time (shorter vs. longer). The results have implications for both risk assessment using the PCL-R and potentially for risk reduction interventions. (PsycINFO Database Record (c) 2015 APA, all rights reserved).

Entities:  

Mesh:

Year:  2014        PMID: 25364945     DOI: 10.1037/per0000095

Source DB:  PubMed          Journal:  Personal Disord        ISSN: 1949-2723


  9 in total

1.  [Therapy drop-out as a predictor of re-delinquency : Legal probation of substance addicted patients according to §64 of the German Legal Code].

Authors:  J Querengässer; J Bulla; K Hoffmann; T Ross
Journal:  Nervenarzt       Date:  2018-01       Impact factor: 1.214

2.  Impact of methadone treatment initiated in jail on subsequent arrest.

Authors:  Sharon M Kelly; Robert P Schwartz; Kevin E O'Grady; Shannon G Mitchell; Tiffany Duren; Anjalee Sharma; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2020-04-04

3.  Emotion-based learning systems and the development of morality.

Authors:  R J R Blair
Journal:  Cognition       Date:  2017-04-07

4.  Gun Violence and Psychopathy Among Female Offenders.

Authors:  Nicholas D Thomson
Journal:  Front Psychol       Date:  2022-06-09

5.  Latent-variable modeling of brain gray-matter volume and psychopathy in incarcerated offenders.

Authors:  Arielle R Baskin-Sommers; Craig S Neumann; Lora M Cope; Kent A Kiehl
Journal:  J Abnorm Psychol       Date:  2016-06-06

6.  Personality disorders, addictions and psychopathy as predictors of criminal behaviour in a prison sample.

Authors:  G Flórez; V Ferrer; L S García; M R Crespo; M Pérez; P A Saiz
Journal:  Rev Esp Sanid Penit       Date:  2019

7.  Comparison between the Psychopathy Checklist-Revised and the Comprehensive Assessment of Psychopathic Personality in a representative sample of Spanish prison inmates.

Authors:  Gerardo Flórez; Ventura Ferrer; Luis S García; María R Crespo; Manuel Pérez; Pilar A Saiz; David J Cooke
Journal:  PLoS One       Date:  2020-02-05       Impact factor: 3.240

8.  BRIEF MOTIVATIONAL INTERVENTION FOR SUBSTANCE USE MAY DECREASE VIOLENCE AMONG HEAVY ALCOHOL USERS IN A JAIL DIVERSION PROGRAM.

Authors:  Imogen Catterall; Sean M Mitchell; Katie Dhingra; Kenneth R Conner; Marc T Swogger
Journal:  Crim Justice Behav       Date:  2020-09-13

9.  Clinician ratings of the Comprehensive Assessment of Psychopathic Personality (CAPP) in a representative sample of Spanish prison inmates: New validity evidence.

Authors:  Gerardo Flórez; Ventura Ferrer; Luis S García; María R Crespo; Manuel Pérez; Pilar A Saíz; David J Cooke
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.